loadpatents
name:-0.014259099960327
name:-0.013369083404541
name:-0.00043797492980957
Co; Man Sung Patent Filings

Co; Man Sung

Patent Applications and Registrations

Patent applications and USPTO patent grants for Co; Man Sung.The latest application filed is for "humanized immunoglobulins".

Company Profile
0.17.13
  • Co; Man Sung - Cupertino CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Humanized antibodies that recognize Verotoxin II and cell line producing same
Grant 7,846,435 - Matsumoto , et al. December 7, 2
2010-12-07
Methods of treatment of autoimmune diseases using humanized immunoglobulin reactive with B7-2
Grant 7,666,421 - Co , et al. February 23, 2
2010-02-23
Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules
Grant 7,531,175 - Co , et al. May 12, 2
2009-05-12
Humanized immunoglobulins
App 20080160018 - Queen; Cary L. ;   et al.
2008-07-03
Methods of treating thrombotic diseases with von Willebrand factor specific antibodies
Grant 7,311,913 - Co , et al. December 25, 2
2007-12-25
Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
Grant 7,138,116 - Co , et al. November 21, 2
2006-11-21
Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith
App 20060251645 - Co; Man Sung ;   et al.
2006-11-09
Method of transplanting cells by contacting donor cells with B7-1-and B7-2-specific immunoglobulins
Grant 6,984,383 - Co , et al. January 10, 2
2006-01-10
Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith
Grant 6,972,125 - Co , et al. December 6, 2
2005-12-06
Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith
App 20050208042 - Co, Man Sung ;   et al.
2005-09-22
Methods of treating thrombotic diseases with von willebrand factor specific antibodies
App 20050197494 - Co, Man Sung ;   et al.
2005-09-08
Increasing antibody affinity by altering glycosylation of immunoglobulin variable region
Grant 6,933,368 - Co , et al. August 23, 2
2005-08-23
Humanized immunoglobulin reactive with B7 therewith
Grant 6,913,747 - Co , et al. July 5, 2
2005-07-05
Humanized immunoglobulin reactive with b7-2 and methods of treatment therewith
Grant 6,827,934 - Co , et al. December 7, 2
2004-12-07
Nanotube-based sensors for biomolecules
App 20040200734 - Co, Man Sung ;   et al.
2004-10-14
Humanized immunoglobulins
App 20040058414 - Queen, Cary L. ;   et al.
2004-03-25
Humanized immunoglobulins
App 20040049014 - Queen, Cary L. ;   et al.
2004-03-11
Humanized immunoglobulins
App 20030229208 - Queen, Cary L. ;   et al.
2003-12-11
Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
App 20030180293 - Co, Man Sung ;   et al.
2003-09-25
Methods of treating thrombotic diseases with von Willebrand factor specific antibodies
Grant 6,613,328 - Co , et al. September 2, 2
2003-09-02
Antithrombotic Agent And Humanized Anti-von Willebrand Factor Monoclonal Antibody
App 20030064068 - Co, Man Sung ;   et al.
2003-04-03
Increasing antibody affinity by altering glycosylation of immunoglobulin variable region
App 20030054497 - Co, Man Sung ;   et al.
2003-03-20
Humanized Immunoglobulin Reactive With B7-2 And Methods Of Treatment Therewith
App 20020176855 - CO, MAN SUNG ;   et al.
2002-11-28
Anti-selectin antibodies for prevention of multiple organ failure after polytrauma and for prevention of acute organ damage after extracorporeal blood circulation
App 20020098183 - Martin, Ulrich ;   et al.
2002-07-25
Antibodies with increased binding affinity
Grant 6,350,861 - Co , et al. February 26, 2
2002-02-26
Humanized antibodies reactive with L-selectin
Grant 6,210,671 - Co
2001-04-03
Anti-Fas ligand antibody and assay method using the anti-Fas ligand antibody
Grant 6,114,507 - Shirakawa , et al. September 5, 2
2000-09-05
Humanized antibodies reactive with GPIIB/IIIA
Grant 5,777,085 - Co , et al. July 7, 1
1998-07-07
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
Grant 5,714,350 - Co , et al. February 3, 1
1998-02-03
Humanized immunoglobulins
Grant 5,693,762 - Queen , et al. De
1997-12-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed